Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Separation or purification
Reexamination Certificate
2006-06-27
2006-06-27
Minnifield, N. M. (Department: 1645)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Separation or purification
C530S402000, C530S403000, C530S422000, C530S810000, C530S350000, C424S234100, C424S193100, C424S190100, C424S191100, C424S203100, C424S244100, C424S266100, C424S265100, C424S279100, C424S278100, C424S282100, C435S243000, C435S259000
Reexamination Certificate
active
07067639
ABSTRACT:
Methods for improving binding of a proteinaceous substance to cell-wall material of a Gram-positive bacterium are disclosed. The proteinaceous substance includes an AcmA cell-wall binding domain, homolog or functional derivative thereof. The method includes treating the cell-wall material with a solution capable of removing a cell-wall component such as a protein, lipoteichoic acid or carbohydrate from the cell-wall material and contacting the proteinaceous substance with the cell-wall material.
REFERENCES:
patent: 5470573 (1995-11-01), Lubitz et al.
patent: 5616686 (1997-04-01), Fischetti et al.
patent: 5786205 (1998-07-01), Fischetti et al.
patent: 5821088 (1998-10-01), Darzins et al.
patent: 5955258 (1999-09-01), Buist et al.
patent: 6027910 (2000-02-01), Klis et al.
patent: 6114147 (2000-09-01), Frenken et al.
patent: 6177083 (2001-01-01), Lubitz
patent: 6423316 (2002-07-01), Riesbeck et al.
patent: 6827940 (2004-12-01), Riordan et al.
patent: 6896887 (2005-05-01), Leenhouts et al.
patent: 2003/0186851 (2003-10-01), Leenhouts et al.
patent: 3919644 (1990-12-01), None
patent: 198 00 746 (1999-07-01), None
patent: 0 545 352 (1993-06-01), None
patent: 0 712 935 (1996-05-01), None
patent: 02065790 (1990-03-01), None
patent: 10117783 (1998-05-01), None
patent: 2002017357 (2002-01-01), None
patent: WO 91/13155 (1991-09-01), None
patent: WO 92/01791 (1992-02-01), None
patent: WO 94/01567 (1994-01-01), None
patent: WO 94/18330 (1994-08-01), None
patent: WO 95/31561 (1995-11-01), None
patent: WO 96/00579 (1996-01-01), None
patent: WO 96/11263 (1996-04-01), None
patent: WO 96/40943 (1996-12-01), None
patent: WO 97/28263 (1997-08-01), None
patent: WO 98/07874 (1998-02-01), None
patent: WO 98/42850 (1998-10-01), None
patent: WO 99/25836 (1999-05-01), None
patent: WO 00/44878 (2000-08-01), None
patent: WO 00/53163 (2000-09-01), None
patent: WO 01-09350 (2001-02-01), None
patent: WO 01/54672 (2001-08-01), None
patent: WO 01/91791 (2001-12-01), None
patent: WO 02/101026 (2002-12-01), None
Pozzi, G. et al. 1992. Delivery and expression of a heterologous antigen on the surface of streptococci. Infection and Immunity. v60(5): 1902-1907.
Fischetti, V.A. et al. 1996. Gram-positive commensal bacteria for mucosal vaccine delivery. Current Opinions in Biotechnology v7: 659-666.
Szostak et al, J. Biotechnology, 1996, 44:161-170.
Paukner et al, J. Controlled Release, 2004, 94:63-74.
Huter et al, J. Controlled Release, 1999, 61:51-63.
Jalava et al, J. Controlled Release, 2002, 85:17-25.
Marchart et al, Vaccine, 2003, 21:1415-1422.
Hatfaludi et al, J. Agric. Food Chem., 2004, 52:5627-5634.
Furst-Ladani et al, Vaccine, 2000, 18:440-448.
Haslberger et al, J. Biotechnology, 2000, 83:57-66.
Paukner et al, J. Drug Targeting, Apr. 2003, 11/3:151-161.
Mayrhofer et al, J. Controlled Release, 2005, 102:725-735.
Hoffelner et al, International J. Medical Microbiology, 2004, 294:303-311.
Tabrizi et al, Current Opinion in Biotechnology, 2004, 15:530-537.
Lubitz, Expert Opinion Biol. Ther., 2001, 1/5:765-771.
Bolotin et al., The Complete Genome Sequence of the Lactic Acid BacteriumLactococcus lactisssp. lactis IL1403, Genome Research, 2001, pp. 731-753, vol. 11.
Brown et al., Comparison of Various Procedures for Removing Proteins and Nucleic Acids from Cell Walls ofBacillus subtilis, 1976, pp 479-88.
Buist et al., Molecular Cloning and Nucleotide Sequence of the Gene Encoding the Major Peptidoglycan Hydrolase ofLactococcus lactis, a Muramidase Needed for Cell Separation, Journal of Bacteriology, Mar. 1995, pp. 1554-1563, vol. 177, No. 6.
Cibik et al., Identification of Mur, an Atypical Peptidoglycan Hydrolase Derived fromLeuconostoc citreum, Applied And Environmental Microbiology, Feb. 2001, pp. 858-864, vol. 67, No. 2.
Gasson et al., Plasmid Complements ofStreptococcus lactisNCDO 712 and Other Lactic Streptococci After Protoplast-Induced Curing, Journal of Bacteriology, Apr. 1983, pp. 1-9, vol. 154, No. 1.
Kok et al., Nucleotide Sequence of the Cell Wall Proteinase Gene ofStreptococcus cremorisWg2, Applied and Environmental Microbiology, Jan. 1988, p. 231-38, vol. 54, No. 1.
Kuipers et al., Controlled overproduction of proteins by lactic acid bacteria, Trends in Biotechnology, Apr. 1997, pp. 135-140, vol. 15.
Medaglini et al., Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacteriumStreptococcus gordoniiafter oral colonization, Proc. Natl. Acad. Sci., Jul. 1995, pp. 6868-6872, vol. 92.
Morata et al., Study of the Morphology of the Cell Walls of Some Strains of Lactic Acid Bacteria and Related Species, Journal of Food Protection, 1998, pp. 557-562, vol. 61, No. 5.
Navarre et al., Proteolytic cleavage and cell wall anchoring at the LPXTG motif of surface proteins in Gram-positive bacteria, Molecular Microbiology, 1994, pp. 115-121, vol. 14, No.1.
Norton et al., Factors affecting the immunogenicity of tetanus toxin fragment C expressed inLactococcus lactis, FEMS Immunology and Medical Microbiology, 1996, pp. 167-177, vol. 14.
Poquet et al., HtrA is the unique surface housekeeping protease inLactococcus lactisand is required for natural protein processing, Molecular Microbiology, 2000, p. 1042-51, vol. 35, No. 5.
Ramasamy et al., Studies on glycoproteins in the human malaria parasitePlasmodium falciparum. Identification of a myristilated 45kDa merozoite membrane glycoprotein, Immunol. Cell Biol., 1987, pp. 419-424, vol. 65, Pt. 5.
Ramasamy et al., Antibodies to a merozoite surface protein promote multiple invasion of red blood cells by malaria parasites, Parasite Immunology, 1999, pp. 397-407, vol. 21.
Robinson et al., Oral vaccination of mice against tetanus with recombinantLactococcus lactis, Nature Biotechnology, Jul. 1997, pp. 653-657, vol. 15.
Sauve et al., Concentration of Dilute Protein for Gel Electrophoresis, Analytical Biochemistry, 1995, pp. 382-383, vol. 226.
Stahl et al., Bacterial surface display: trends and progress, Trends in Biotechnology, pp. 185-192, vol. 15.
European Search Report, EP 01 20 2239, dated Jan. 14, 2002.
Buist Girbe
Kok Jan
Kuipers Oscar P.
Leenhouts Cornelis J.
Ramasamy Ranjan
Applied Nanosystems B.V.
Minnifield N. M.
TraskBritt
LandOfFree
Method to provide bacterial ghosts provided with antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method to provide bacterial ghosts provided with antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method to provide bacterial ghosts provided with antigens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3663681